Barr Pharmaceuticals

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Barr Pharmaceuticals, Inc.
Industry Pharmaceutical industry
Fate Acquired by Teva Pharmaceutical Industries
Founded 1970; 48 years ago (1970)
Defunct December 23, 2008; 9 years ago (December 23, 2008)
Headquarters Montvale, New Jersey
Key people
Bruce L. Downey, Chairman & CEO
William T. McKee, CFO
Products Generic drugs
Revenue Increase $2.500 billion (2007)
Increase $0.128 billion (2007)
Total assets Decrease $4.761 billion (2007)
Total equity Increase $1.866 billion (2007)
Number of employees
8,900 (2007)
Footnotes / references

Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.

Approximately 75% of the company's revenues were from the sale of generic drugs, including 18% of sales which were from the sale of oral contraceptive pills.[1]

It was acquired by Teva Pharmaceutical Industries in 2008.[2]


Barr Laboratories Inc. was founded in New York in 1970 by Edwin A. Cohen.[3]

In 1993, Bruce L. Downey joined the company as its president and in 1994, he became chairman and chief executive officer of the company.[4]

In 1993, the company settled a patent infringement case and began distributing a generic version of tamoxifen citrate, a treatment for breast cancer.[5]

In 1995, the company received approval to manufacture and sell a generic version of zidovudine (AZT), a treatment for AIDS.[6]

In 1996, the company became the first to receive approval from the Food and Drug Administration to market generic Warfarin, which was previously only sold by DuPont.[7]

In 2001, the company acquired Duramed Pharmaceuticals for $589 million in stock.[8]

In August 2001, after a 5-year legal battle with Eli Lilly and Company, the company began selling a generic version of Prozac.[9]

In 2003, the company acquired Endeavor Pharmaceuticals for $35 million.[10]

In October 2006, the company acquired Pliva.[11]

On December 23, 2008, the company was acquired by Teva Pharmaceutical Industries and became part of Teva Active Pharmaceutical Ingredients (TAPI).[2]